Quantcast

Latest gout Stories

2011-10-03 19:44:55

Comfort, fit, support and cost important factors in selecting footwear New research shows that use of poor footwear is common among patients with gout. According to the study published today in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), gout patients who make poor footwear choices experienced higher foot-related pain, impairment and disability. Gout patients also reported that comfort, fit, support and cost were the most important...

2011-08-16 23:25:47

As an alternative to a conventional treatment for gout that some patients may not respond to, patients with severe, chronic gout who received the medication pegloticase for 6 months had greater improvement in measures of uric acid levels as well as physical function and quality of life, according to a study in the August 17 issue of JAMA. Long-term urate (a salt derived from uric acid) lowering therapy in gout aims to maintain concentrations of uric acid (UA) below a certain level. However,...

2011-08-16 23:21:17

Injections of pegloticase, a modified porcine enzyme, can produce significant and sustained clinical improvements in 2 out of 5 patients with chronic gout that is resistant to conventional therapies, researchers report in the August 17, 2011, issue of JAMA. In two controlled clinical trials, pegloticase rapidly lowered high levels of uric acid, the biochemical abnormality in gout, and kept it in the normal range for six months or more in 42 percent of patients receiving the drug every two...

2011-08-16 15:01:00

EAST BRUNSWICK, N.J., Aug. 16, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that results from two pivotal KRYSTEXXA® (pegloticase) Phase III clinical studies in patients with refractory chronic gout (RCG) have been published in The Journal of the American Medical Association (JAMA). The data demonstrated that treatment with KRYSTEXXA resulted in significant and sustained reductions in uric acid levels along with clinical...

2011-08-11 12:31:00

PHILADELPHIA, Aug. 11, 2011 /PRNewswire/ -- Newly-published results from a series of colchicine safety studies provide physicians with the first evidence-based dosing guidance for colchicine when co-administered with certain commonly prescribed drugs, helping doctors and patients avoid serious and potentially life-threatening drug-drug interactions. The study results, published in a paper titled "Evidence Basis of a Novel Colchicine Dose Reduction Algorithm to Predict and Prevent...

2011-08-08 15:15:00

ISELIN, N.J., Aug. 8, 2011 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) today reported financial results for the second quarter and six-month period ended June 30, 2011. These results are included in the Company's Quarterly Report on Form 10-Q which has been filed with the SEC. Second Quarter Ended June 30, 2011 The Company recorded a net loss of $0.5 million, or $0.01 per share, for the second quarter 2011 compared to a net loss of $0.4 million, or $0.01 per share, in the second...

2011-08-05 07:30:00

SAN DIEGO, Aug. 5, 2011 /PRNewswire/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, today reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2011. "Since our last quarterly update, we presented exciting initial results from the ongoing extension portion of our Phase 2b trial of lesinurad demonstrating high rates of...

2011-07-29 06:26:57

(Ivanhoe Newswire) -- New research suggests the prevalence of gout has risen over the past 20 years in the United States. Gout is an inflammatory arthritis that is triggered by crystallization of uric acid within the joints. The condition causes severe pain and swelling. Gout is linked to metabolic syndrome -- a group of health conditions characterized by obesity, insulin resistance, high blood pressure and blood lipid problems. In this new study, researchers found gout now affects about 8.3...

2011-07-28 17:22:21

Increase in obesity and hypertension are likely contributors A new study shows the prevalence of gout in the U.S. has risen over the last twenty years and now affects 8.3 million (4%) Americans. Prevalence of increased uric acid levels (hyperuricemia) also rose, affecting 43.3 million (21%) adults in the U.S. Greater frequency of obesity and hypertension may be associated with the jump in prevalence rates according to the findings now available in Arthritis & Rheumatism, a journal...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.